Inventor · disambiguated record
Yun-Xing Cheng
Also filed as: CHENG YUN · CHENG YUN-XING
14 granted patents·38 pending applications·159 citations·filing 2001–2024
90Inventor score
Top patents by PatentIndex Score
52 records- 0193US6784161B2Method for the treatment or prevention of flavivirus infections using nucleoside analoguesIAF BIOCHEM INT·Filed 2001·Granted Aug 31, 2004·94 cites·38 claims
- 0291US9346815B25-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2015·Granted May 24, 2016·5 cites·20 claims
- 0389US7030139B2CompoundsASTRAZENECA AB·Filed 2002·Granted Apr 18, 2006·37 cites·6 claims
- 0488US9604984B25-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2016·Granted Mar 28, 2017·4 cites·21 claims
- 0586US10307426B2Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2018·Granted Jun 4, 2019·4 cites·29 claims
- 0680US8119661B2Piperidine derivatives and their use as muscarinic receptor modulatorsCHENG YUN-XING·Filed 2008·Granted Feb 21, 2012·11 cites·1 claims
- 0775US2023242530A18-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereofGENENTECH INC·Filed 2023·Application pending·0 cites
- 0874US11155557B2Pyrazolopyrimidine compounds and methods of use thereofGENENTECH INC·Filed 2019·Granted Oct 26, 2021·1 cites·19 claims
- 0973US9873709B2Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2017·Granted Jan 23, 2018·1 cites·14 claims
- 1073US7956069B2CompoundsASTRAZENECA AB·Filed 2007·Granted Jun 7, 2011·2 cites·2 claims
- 1172US2023206644A1Pyrazolopyrimidine compounds as jak inhibitorsGENENTECH INC·Filed 2023·Application pending·0 cites
- 1272US2025042919A1Tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 1372US2022204517A1Inhaled powder formulationsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1470US2022024945A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 1569US2019322661A15-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 1668US12247032B2Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of JAK kinasesGENENTECH INC·Filed 2022·Granted Mar 11, 2025·0 cites·1 claims
- 1768US2019240227A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 1865US2020352951A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 1964US11731943B2Therapeutic compounds, compositions and methods of use thereofGENENTECH INC·Filed 2021·Granted Aug 22, 2023·0 cites·8 claims
- 2064US2023016791A1Inhalable dry powder and aerosol formulations of jak inhibitorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 2164US2018305355A15-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 2262US2019202822A18-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 2362US2022281893A1Tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2022·Application pending·0 cites
- 2461US2020339604A1Pyrazolopyrimidine compounds as jak inhibitorsGENENTECH INC·Filed 2020·Application pending·0 cites
- 2561US2020165260A1Inhaled powder formulationsGENENTECH INC·Filed 2020·Application pending·0 cites
- 2661US2020270248A18-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 2760US2017145020A15-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 2860US2019233441A1Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 2959US2020062779A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 3059US2019337946A1Triazolopyridine compounds and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 3158US2004248844A1Method for the treatment or prevention of Flavivirus infections using nucleoside analoguesFiled 2004·Application pending·0 cites
- 3257US11453671B2Pyrazolopyrimidine inhibitors of JAK kinases and uses thereofGENENTECH INC·Filed 2020·Granted Sep 27, 2022·0 cites·12 claims
- 3357US2020399274A1Tetrazole-substituted pyrazolopyrimidine inhibitors of jak kinases and uses thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 3457US2018298033A1Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 3556US2018265515A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 3656US2018327402A1Triazolopyridine compounds and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 3756US2018334465A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 3855US12358951B2Cyclic peptide antibioticsGENENTECH INC·Filed 2021·Granted Jul 15, 2025·0 cites·22 claims
- 3954US2018086757A1Triazolopyridine compounds and methods of use thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 4053US2024383915A1Oxazepine compounds and uses thereof in the treatment of cancerGENENTECH INC·Filed 2022·Application pending·0 cites
- 4152US2016185780A1Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2016·Application pending·0 cites
- 4252US2019071404A1Therapeutic compounds, compositions and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 4350US2006135554A1Novel compoundsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4448US2009221567A1Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 4548US2009275574A1Novel compounds-300ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 4645US2007259888A1Novel CompoundsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 4745US2010173941A1Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and SchizophreniaASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 4844US2010173935A1Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and SchizophreniaASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 4942US2007037140A1Methods and compositions for detecting sars virusUNIV TSINGHUA·Filed 2003·Application pending·0 cites
- 5042US2010113502A1Novel Tetrahydro-1H-Pyrido[4,3-b] Indole Derivatives as CB1 Receptor LigandsASTRAZENECA AB·Filed 2006·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yun-Xing Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →